A shipment of vials of remdesivir intended for clinical trial use. Gilead Sciences invested millions of dollars of independent research and development funding to develop the drug, which, until COVID-19, seemed to have a very small but promising market in helping treat Ebola virus disease.
| Date Taken: | 01.13.2021 |
| Date Posted: | 05.06.2021 10:00 |
| Photo ID: | 6633133 |
| VIRIN: | 210113-A-ZM081-001 |
| Resolution: | 1536x864 |
| Size: | 159.23 KB |
| Location: | US |
| Web Views: | 56 |
| Downloads: | 6 |
This work, READY FOR ITS CLOSEUP, must comply with the restrictions shown on https://www.dvidshub.net/about/copyright.
